Oncogenomics handbook /

Saved in:
Bibliographic Details
Imprint:Totowa, N.J. : Humana Press, c2005.
Description:1 online resource (xvii, 750 p.) : ill.
Language:English
Series:Cancer drug discovery and development
Cancer drug discovery and development.
Subject:
Format: E-Resource Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/8877351
Hidden Bibliographic Details
Other authors / contributors:Larochelle, William J.
Shimkets, Richard A.
ISBN:9781592598939
1592598935
1588294250
9781588294258
Notes:Includes bibliographical references and index.
Description based on print version record.
Summary:This is an integrated overview of cancer drug discovery and development from the bench to the clinic, showing with broad strokes and representative examples the drug development process as a network of linked components leading from the discovered target to the ultimate therapeutic product. Following a systems biology approach, the authors explain genomic databases and how to discover oncological targets from them, how then to advance from the gene and transcript to the level of protein biochemistry, how next to move from the chemical realm to that of the living cell and, ultimately, pursue an.
Other form:Print version: Oncogenomics handbook. Totowa, N.J. : Humana Press, c2005 1588294250 9781588294258
Description
Summary:An integrated overview of cancer drug discovery and development from the bench to the clinic, showing with broad strokes and representative examples the drug development process as a network of linked components leading from the discovered target to the ultimate therapeutic product. Following a systems biology approach, the authors explain genomic databases and how to discover oncological targets from them, how then to advance from the gene and transcript to the level of protein biochemistry, how next to move from the chemical realm to that of the living cell and, ultimately, pursue animal modeling and clinical development. Emerging cancer therapeutics including Ritux an, Erbitux, Gleevec Herceptin, Avastin, ABX-EGF, Velcade, Kepivance, Iressa, Tarceva, and Zevalin are addressed. Highlights include cancer genomics, pharmacogenomics, transcriptomics, gene expression analysis, proteomic and enzymatic cancer profiling technologies, and cellular and animal approaches to cancer target validation.
Physical Description:1 online resource (xvii, 750 p.) : ill.
Bibliography:Includes bibliographical references and index.
ISBN:9781592598939
1592598935
1588294250
9781588294258